FEB 28, 2019 7:00 AM PST

ELISA-like Assay Formats and the Benefits of Assay Automation

Speaker
  • Scientist IV - Antibody Generation - Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc.
    Biography
      I attended the University of Connecticut where I received my Bachelors Degree in Physiology/Neurobiology in 1999. I then attended graduate school at Southern Connecticut State University where I earned my Master's Degree in Biology. I have worked at Yale School of Medicine, Perkin Elmer, Thermo Electron, Pfizer and am currently employed at Boehringer Ingelheim Pharmaceuticals. The majority of my expertise is in immunoassay development and validation. I also have extensive experience in lab automation and integration. I served in the US Army as a Medic for 12 years attaining the rank of Staff Sergeant and completing tours of duty in Bosnia in 2001 and Iraq in 2005. My current duties are in overseeing Boehringer's High Throughput Antibody Discovery team, whose principal duties are primary screening, cloning and transient expression of therapeutic antibody candidates.

    Abstract
    DATE:    February 28, 2019
    TIME:    7:00 AM PST, 10:00 AM EST
     
    Bringing automation on any scale into your lab can be an intimidating prospect, especially for new users. There can be significant benefits to automating a method or process, but there are also many factors to consider and even more potential pitfalls. It is a common misconception that automation or integrated platforms have to be big, expensive and complex. There is also a common misconception that less complex assay formats don’t benefit from automation. Implementing automation can be as complex as large, walk-away high-throughput screening platforms or as simple as a plate reader and stacker, or any combination in between. Thoughtful planning and careful implementation are the two factors that determine the overall success of the process.
     
    This webinar will explore the benefits of automating less complex assay formats while also addressing some of the considerations that need to be examined, such as scope, scale and cost. We will focus on ELISA and “ELISA-like” assay formats and provide an example of an existing integration used for MSD-based antibody discovery.
     
     
    Learning objectives:
    • Understanding of the many variants of the classic ELISA assay as well as newer, “ELISA-like” assay formats and the benefits that they bring.
    • Understand key challenges to automating assay methods or entire processes.
     
    LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

    Show Resources
    You May Also Like
    APR 07, 2020 8:00 AM PDT
    C.E. CREDITS
    APR 07, 2020 8:00 AM PDT
    DATE: April 7, 2020 TIME: 8:00am PT, 11:00am ET This webinar sets out to establish why quality control is key to robust, reliable, reproducible science. We will look at best practice criteri...
    FEB 26, 2020 9:00 AM PST
    C.E. CREDITS
    FEB 26, 2020 9:00 AM PST
    DATE: February 26, 2020 TIME: 9:00am PST 3D cell culture and analysis and the study of organoids and spheroids are becoming more prevalent as a research method in publications as traditional...
    JUN 23, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 23, 2020 10:00 AM PDT
    DATE: June 23, 2020 TIME: 10:00am PT Human mesenchymal stromal or stem cells (MSCs)-based immunomodulation treatment has been proposed as a suitable therapeutic approach for many diseases, s...
    JUN 17, 2020 1:30 PM PDT
    C.E. CREDITS
    JUN 17, 2020 1:30 PM PDT
    Understanding the complex interplay between a pathogen and the host response is important to developing effective vaccines and therapeutics. The nCounter® Analysis System and GeoMx®...
    FEB 19, 2020 11:00 AM PST
    C.E. CREDITS
    FEB 19, 2020 11:00 AM PST
    DATE: February 19, 2020TIME: 11:00am PST, 2:00pm EST...
    APR 27, 2020 9:00 AM PDT
    C.E. CREDITS
    APR 27, 2020 9:00 AM PDT
    DATE: April 27, 2020 TIME: 9:00am PT, 12:00pm ET Recombinant adeno-associated virus (rAAV) is a small (25-nm) virus that is composed of a protein shell called a capsid and a single-stranded...
    Loading Comments...
    Show Resources
    Attendees
    • See more